Skip to main content
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.050
+0.040 (1.99%)
At close: Jun 2, 2025, 4:00 PM
2.040
-0.010 (-0.49%)
After-hours: Jun 2, 2025, 4:38 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Protein Kinase Inhibitor Therapeutics
260.50K
Log In
Log In
Log In
Log In
Upgrade
Protein Kinase Inhibitor Therapeutics Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
260.50K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade